David Mountcastle compensation by year
Privia Health Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $390,000 |
| Bonus | $0 |
| Stock awards | $2,147,067 |
| Option awards | $0 |
| Non-equity incentive | $468,000 |
| Pension and deferred compensation | $0 |
| All other | $15,575 |
| Total | $3,020,642 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Privia Health Group, Inc. DEF 14A filed April 2, 2026, accession 0001193125-26-138997, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 57,088 | $1,353,556 | — |
| PSU | 50,146 | $1,188,962 | — |
| RSU | 39,856 | $955,458 | — |
| PSU | 33,430 | $792,625 | — |
| PSU | 33,088 | $784,516 | — |
| PSU | 25,373 | $601,594 | — |
| PSU | 12,209 | $289,475 | — |
| PSU | 7,353 | $174,340 | — |
| Option | 16,221 | — | $26.73 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Privia Health Group, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
23 Form 4 lines since the FY2025 proxy (filed April 2, 2026)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-07-09 | Sale | 10b5-1 | 21,275 | $27.67 | 164,853 |
| 2026-07-07 | Sale | 10b5-1 | 600 | $27.57 | 186,128 |
| 2026-07-02 | Sale | 10b5-1 | 24,734 | $27.50 | 186,728 |
| 2026-06-26 | Exercise or conversion derivative | 10b5-1 | 1,001 | $0.00 | 0 |
| 2026-06-26 | Exercise or conversion derivative | 10b5-1 | 8,897 | $0.00 | 0 |
| 2026-06-26 | Exercise or conversion derivative | 10b5-1 | 5,962 | $0.00 | 0 |
| 2026-06-26 | Exercise or conversion | 10b5-1 | 17,196 | $2.00 | 228,658 |
| 2026-06-26 | Exercise or conversion derivative | 10b5-1 | 1,336 | $0.00 | 0 |
The 8 most recent of 23 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Privia Health discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $702,000 | $5,569,645 | $32,477 | $6,304,122 |
| Change in control, no termination | — | $5,569,645 | — | $5,569,645 |
| Involuntary termination without cause | $702,000 | $1,858,010 | $32,477 | $2,592,487 |
| Resignation for good reason, no change in control | $702,000 | $1,858,010 | $32,477 | $2,592,487 |
| Change in control and resignation for good reason | $702,000 | $5,569,645 | $32,477 | $6,304,122 |
Per the Potential Payments Upon Termination or Change in Control table in Privia Health Group, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Privia Health’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Parth Mehrotra | Chief Executive Officer | $10,472,698 |
| David Mountcastle · this page | Executive Vice President & Chief Financial Officer | $3,020,642 |
| Edward Fargis | Executive Vice President & General Counsel | $2,357,376 |
The full Privia Health compensation record
free company briefThis page is one person within Privia Health's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Privia Health's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Privia Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat